Antenatal glucocorticoids increase early total thyroxine levels in premature infants

Camilia R Martin1, Linda J Van Marter, Elizabeth N Allred

  • 1Department of Neonatology, Beth Israel Deaconess Medical Center, Division of Newborn Medicine, Boston, MA 02215, USA. cmartin1@bidmc.harvard.edu

Biology of the Neonate
|February 11, 2005
PubMed

Insights

Antenatal glucocorticoids, used to support preterm delivery, were associated with higher early total thyroxine (T4) levels in extremely premature infants. This finding suggests a potential influence on neonatal thyroid function.

Area of Science:

  • Neonatalogy
  • Endocrinology
  • Obstetrics

Background:

  • Hypothyroxinemia in premature infants is linked to severe adverse outcomes, including neurodevelopmental deficits and mortality.
  • Understanding factors influencing thyroid function in preterm neonates is critical.
  • Antenatal glucocorticoid exposure is common in threatened preterm deliveries, but its impact on neonatal thyroid function is understudied.

Purpose of the Study:

  • To investigate the association between antenatal glucocorticoid exposure and early total thyroxine (T4) levels in extremely premature infants.
  • To determine if antenatal glucocorticoids modify neonatal thyroid hormone levels shortly after birth.

Main Methods:

  • A cohort of 521 infants born between 23-28 weeks gestational age was studied across four medical centers.
  • Serum total T4 levels were measured in the first postnatal week, sourced from newborn screening programs.
  • Antenatal glucocorticoid exposure was categorized as none, partial, or complete, with a complete course defined by specific betamethasone or dexamethasone dosing.

Main Results:

  • Infants receiving a complete course of antenatal glucocorticoids exhibited significantly higher total T4 levels (0.8 microg/dl greater) compared to unexposed infants (p = 0.03).
  • This association persisted after controlling for maternal, perinatal, and neonatal confounding factors.
  • The observed increase in T4 levels was statistically significant, indicating a potential biological effect.

Conclusions:

  • Complete antenatal glucocorticoid administration is associated with elevated total thyroxine levels in the first week of life for extremely premature infants.
  • The relationship between antenatal glucocorticoids and neonatal thyroid function is not fully explained by known confounding variables.
  • These findings suggest that antenatal glucocorticoids may directly influence early thyroid hormone regulation in preterm neonates.
Abstract

Related Concept Videos

Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
Transcytosis of IgG01:15

Transcytosis of IgG

Transcytosis is the process in which molecules are internalized by endocytosis, transported across the cell, and released through exocytosis from the opposite end of the cell. Molecules such as insulin, immunoglobulins, and certain nutrients are transferred through the recycling endosomes by recycling and transcytosis.
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...